CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 3 filers reported holding CTI BIOPHARMA CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $148,025 | -29.3% | 35,244 | +1.1% | 0.00% | – |
Q4 2022 | $209,460 | -93.3% | 34,852 | -93.5% | 0.00% | -100.0% |
Q3 2022 | $3,125,000 | -62.1% | 536,883 | -61.1% | 0.00% | -50.0% |
Q2 2022 | $8,238,000 | +25.7% | 1,379,906 | -1.7% | 0.00% | 0.0% |
Q1 2022 | $6,555,000 | +50323.1% | 1,403,614 | +8024.6% | 0.00% | – |
Q4 2018 | $13,000 | -64.9% | 17,276 | +0.2% | 0.00% | – |
Q3 2018 | $37,000 | -58.0% | 17,249 | -2.2% | 0.00% | – |
Q2 2018 | $88,000 | – | 17,633 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 5,302,063 | $11,452,000 | 6.70% |
BVF INC/IL | 6,929,690 | $14,968,000 | 1.32% |
Opaleye Management Inc. | 1,550,000 | $3,348,000 | 0.85% |
CAXTON CORP | 197,459 | $427,000 | 0.40% |
NEA Management Company, LLC | 3,750,000 | $8,100,000 | 0.35% |
ALGERT GLOBAL LLC | 339,349 | $733,000 | 0.16% |
Orbimed Advisors | 5,000,000 | $10,800,000 | 0.13% |
Alambic Investment Management, L.P. | 35,665 | $77,000 | 0.06% |
OXFORD ASSET MANAGEMENT LLP | 433,002 | $928,000 | 0.02% |
SECTORAL ASSET MANAGEMENT INC | 32,241 | $70,000 | 0.01% |